QSG-7701 is not a Normal hepatocyte line: Reassessing the claimed selectivity of mitochondria-targeted podophyllotoxin derivatives

Authors: Weiskirchen, Ralf

Source journal: Bioorganic & medicinal chemistry letters (2026-11-15)

DOI: 10.1016/j.bmcl.2026.130814

Abstract

This communication addresses a critical interpretation issue in a recent study on mitochondria-targeted podophyllotoxin derivatives for liver cancer therapy. The authors used QSG-7701 as a normal hepatocyte comparator to calculate selectivity indices, although QSG-7701 has been reported to be HeLa-derived. HepG2, the principal liver tumor cell model examined, is hepatoblastoma-derived rather than hepatocellular carcinoma-derived. For compound 6d, the reported ratio of 2.29 therefore represents a modest difference in potency between two tumor-derived cell lines, not selectivity for liver tumor cells over normal hepatocytes. This misclassification undermines conclusions concerning reduced normal hepatocyte toxicity and a therapeutic window, without necessarily invalidating the reported antiproliferative, mitochondrial colocalization, or apoptosis findings. Assessment of normal hepatocyte sparing requires authenticated and appropriately validated non-malignant human liver models.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.